51 - 75 of 34.888
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Airbnb Inc-Class A Call 130,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 10,97x
- Analysis
- AMD Call 160,00 5 Sep 2025
- Goldman Sachs
- 05.09.25
- 7,90x
- Analysis
- Palantir Technologies Call 260,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 13,76x
- Analysis
- Sempra Energy Call 80,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 12,79x
- Analysis
- Alphabet Call 240,00 5 Sep 2025
- Goldman Sachs
- 05.09.25
- 20,68x
- Analysis
- Alphabet Call 240,00 12 Sep 2025
- Goldman Sachs
- 12.09.25
- 20,85x
- Analysis
- Sempra Energy Call 90,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 18,82x
- Analysis
- Alphabet Call 220,00 5 Sep 2025
- Goldman Sachs
- 05.09.25
- 21,10x
- Analysis
- Alphabet Call 220,00 12 Sep 2025
- Goldman Sachs
- 12.09.25
- 19,08x
- Analysis
- Alphabet Call 240,00 29 Aug 2025
- Goldman Sachs
- 29.08.25
- 23,48x
- Analysis
- Alphabet Call 220,00 22 Aug 2025
- Goldman Sachs
- 22.08.25
- 28,52x
- Analysis
- AMD Call 160,00 22 Aug 2025
- Goldman Sachs
- 22.08.25
- 9,80x
- Analysis
- Microsoft Call 505,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 11,27x
- Analysis
- Amazon.com Call 212,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 8,98x
- Analysis
- Fresenius Medical Care Call 50,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 10,56x
- Analysis
- Microsoft Call 535,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 15,50x
- Analysis
- Amazon.com Call 218,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 10,01x
- Analysis
- Fresenius Medical Care Call 35,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,31x
- Analysis
- Amazon.com Call 214,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 9,36x
- Analysis
- Teva Pharmaceutical Industries Call 17,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 8,67x
- Analysis
- Fresenius Medical Care Call 50,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 3,73x
- Analysis
- Fresenius Medical Care Call 40,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,72x
- Analysis
- Amazon.com Call 228,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 16,93x
- Analysis
- Novo Nordisk Call 265,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,10x
- Analysis
- Novo Nordisk Call 335,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,36x
- Analysis